Slide 1: Q4 2020 Earnings Call
Q4 2020 Earnings Call February 10, 2021 © 2021. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.
Slide 2: Legal: Safe Harbor Statement
Legal This presentation should be viewed in conjunction with IQVIA’s Q4 2020 earnings call Safe Harbor Statement for Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 19
Slide 3: Legal: Non-GAAP Information
Legal Non-GAAP Information This presentation includes information based on financial measures that are not recognized under generally accepted accounting principles in the United States (“GAAP”), such as Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted Earnings per Share. Non-GAAP financial me
Slide 4: 4th Quarter Results
4th Quarter Results $M, except per share data Revenue Adjusted EBITDA(1) Adjusted Diluted EPS(1) 13.9% AFx 14.5% AFx 21.3% AFx 12.2% CFx $3,298 $2.11 $735 $2,895 $642 $1.74 Q4 2020 Q4 2019 Q4 2020 Q4 2019 Q4 2020 Q4 2019 Dollars are at actual foreign exchange rates. AFx is actual currency. CFx is co
Slide 5: 4th Quarter and Full-Year Revenue
4th Quarter and Full-Year Revenue $M Q4 Full Year VPY% VPY% VPY% VPY% 2020 2019 2020 2019 AFx CFx AFx CFx Technology & Analytics $1,425 $1,214 17.4% 15.1% $4,858 $4,486 8.3% 8.1% Solutions Research & $1,684 $1,471 14.5% 13.2% $5,760 $5,788 (0.5)% (0.7)% Development Solutions Contract Sales & $189 $2
Slide 6: 4th Quarter and Full-Year Profit
4th Quarter and Full-Year Profit $M, except per share data Q4 Full Year 2020 2019 2020 2019 Adjusted EBITDA (1) $735 $642 $2,384 $2,400 Net Income $119 $16 $279 $191 Diluted Earnings per Share $0.61 $0.09 $1.43 $0.96 Adjusted Net Income (1) $411 $343 $1,252 $1,276 Adjusted Diluted Earnings $2.11 $1.
Slide 7: R&D Solutions Backlog and NTM Revenue
R&D Solutions Backlog and NTM Revenue $B Backlog Next Twelve Months Revenue +18.5% $22.6 $5.9 +13.5% $19.0 $5.2 Q4 2019 Q4 2020 Q4 2019 Q4 2020 6 Dollars are at actual foreign exchange rates. NTM: Next Twelve Months
Slide 8: 4th Quarter Balance Sheet and Cash Flow Items and Metrics
4th Quarter Balance Sheet and Cash Flow Items and Metrics $M Cash & Cash Equivalents $1,814 Gross Debt $12,533 Net Debt $10,719 Gross Leverage Ratio (1) 5.3x Net Leverage Ratio (1) 4.5x Net Cash Provided by Operating Activities $750 Capital Expenditures $176 Free Cash Flow $574 Dollars are at actual
Slide 9: Full-Year 2021 Guidance
Full-Year 2021 Guidance $M, except per share data Updated Prior(1) Revenue $12,550 - $12,900 $12,300 - $12,600 Adjusted EBITDA $2,760 - $2,840 $2,725 - $2,800 Adjusted Diluted EPS $7.77 - $8.08 $7.65 - $7.95 (1) Provided on Q3 2020 earnings call on October 20, 2020. Guidance assumes current foreign
Slide 10: Full-Year 2021 Segment Revenue Growth Guidance
Full-Year 2021 Segment Revenue Growth Guidance VPY% Technology & Analytics Solutions 9% – 12% Research & Development Solutions 14% – 17% Contract Sales & Medical Solutions ~(2)% Growth rates are at actual foreign exchange rates. 9 Guidance assumes current foreign currency rates remain in effect for
Slide 11: Q1 2021 Guidance
Q1 2021 Guidance $M, except per share data Guidance VPY% Revenue $3,150 – $3,200 14.4% – 16.2% Adjusted EBITDA $660 – $675 17.4% – 20.1% Adjusted Diluted EPS $1.81 – $1.87 20.7% – 24.7% Dollars and growth rates are at actual foreign exchange rates. 10 Guidance assumes current foreign currency rates
Slide 12: Q&A
Q&A 11
Slide 13: Appendix
SSlIQVIA Appendix
Slide 14: Consolidated Statements of Income
Consolidated Statements of Income $M, except per share data Three Months Ended Twelve Months Ended December 31, December 31, 2020 2019 2020 2019 Revenues $ 3,298 $ 2,895 $ 11,359 $ 11,088 Costs of revenue, exclusive of depreciation and amortization 2,172 1,901 7,500 7,300 Selling, general and admini
Slide 15: Net Income to Adjusted EBITDA Reconciliation
Net Income to Adjusted EBITDA Reconciliation $M Three Months Ended Twelve Months Ended December 31, December 31, 2020 2019 2020 2019 Net Income Attributable to IQVIA Holdings Inc. $ 119 $ 16 $ 279 $ 191 Provision for income taxes 63 68 72 116 Depreciation and amortization 344 314 1,287 1,202 Interes
Slide 16: Net Income to Adj. Net Income and Per Share Data Reconciliation
Net Income to Adj. Net Income and Per Share Data Reconciliation $M, except per share data Three Months Ended Twelve Months Ended December 31, December 31, 2020 2019 2020 2019 Net Income Attributable to IQVIA Holdings Inc. $ 119 $ 16 $ 279 $ 191 Provision for income taxes 63 68 72 116 Purchase accoun
Slide 17: Leverage Ratios
Leverage Ratios $M Gross Debt, net of Original Issue Discount, as of December 31, 2020 $ 12,533 Net Debt as of December 31, 2020 $ 10,719 Adjusted EBITDA for the twelve months ended December 31, 2020 $ 2,384 Gross Leverage Ratio (Gross Debt/LTM Adjusted EBITDA) 5.3x Net Leverage Ratio (Net Debt/LTM